VanEck ETF Trust - VanEck Biotech ETF
US ˙ NasdaqGM ˙ US92189F7261

SecurityBBH / VanEck ETF Trust - VanEck Biotech ETF
InstitutionCommonwealth Equity Services, Llc
Latest Disclosed Ownership9,643 shares
Latest Disclosed Value $ 1,825,080
Commonwealth Equity Services, Llc reports 4.80% decrease in ownership of BBH / VanEck ETF Trust - VanEck Biotech ETF

On February 12, 2026 - Commonwealth Equity Services, Llc filed a 13F-HR form disclosing ownership of 9,643 shares of VanEck ETF Trust - VanEck Biotech ETF (US:BBH) valued at $1,825,081 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 22, 2025 disclosing 10,129 shares of VanEck ETF Trust - VanEck Biotech ETF. This represents a change in shares of -4.80% during the quarter. The current value of the position is $1,827,216 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-12 2025-12-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 9,643 -486 -4.80 1,825 182,400.00 0.0024
2025-10-22 2025-09-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 10,129 -629 -5.85 2 0.00 0.0022
2025-08-06 2025-06-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 10,758 -17,851 -62.40 2 -75.00 0.0022
2025-05-09 2025-03-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 28,609 -1,834 -6.02 5 0.00 0.0064
2025-02-10 2024-12-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 30,443 -338 -1.10 5 -20.00 0.0070
2024-10-18 2024-09-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 30,781 555 1.84 5 0.00 0.0083
2024-07-31 2024-06-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 30,226 -200 -0.66 5 0.00 0.0081
2024-04-29 2024-03-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 30,426 340 1.13 5 25.00 0.0084
2024-02-06 2023-12-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 30,086 1,381 4.81 5 0.00 0.0091
2023-10-23 2023-09-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 28,705 495 1.75 4 0.00 0.0093
2023-08-10 2023-06-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 28,210 11,182 65.67 4 100.00 0.0090
2023-05-11 2023-03-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 17,028 -307 -1.77 3 0.00 0.0058
2023-02-07 2022-12-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 17,335 -478 -2.68 3 -99.92 0.0067
2022-11-14 2022-09-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 17,813 -3,524 -16.52 2,507 -19.39 0.0065
2022-07-19 2022-06-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 21,337 -6,533 -23.44 3,110 -31.16 0.0081
2022-05-04 2022-03-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 27,870 10,352 59.09 4,518 36.25 0.0103
2022-01-31 2021-12-31 13F VANECK ETF TRUST BIOTECH ETF 92189F726 17,518 826 4.95 3,316 -1.72 0.0075
2021-10-29 2021-09-30 13F VANECK ETF TRUST BIOTECH ETF 92189F726 16,692 -177 -1.05 3,374 -0.82 0.0085
2021-08-11 2021-06-30 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 16,869 727 4.50 3,402 20.13 0.0086
2021-05-04 2021-03-31 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 16,142 -280 -1.71 2,832 1.65 0.0080
2021-02-11 2020-12-31 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 16,422 943 6.09 2,786 11.08 0.0084
2020-11-05 2020-09-30 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 15,479 1,145 7.99 2,508 7.41 0.0086
2020-08-12 2020-06-30 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 14,334 5,498 62.22 2,335 106.45 0.0088
2020-05-11 2020-03-31 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 8,836 -222 -2.45 1,131 -10.38 0.0053
2020-02-05 2019-12-31 13F VANECK VECTORS ETF TRUST BIOTECH ETF 92189F726 9,058 -734 -7.50 1,262 9.26 0.0048
2019-10-30 2019-09-30 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 9,792 -1,047 -9.66 1,155 -17.32 0.0049
2019-07-19 2019-06-30 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 10,839 -4,209 -27.97 1,397 -27.73 0.0062
2019-05-13 2019-03-31 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 15,048 -393 -2.55 1,933 13.11 0.0089
2019-02-11 2018-12-31 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 15,441 -2,534 -14.10 1,709 -30.10 0.0091
2018-11-06 2018-09-30 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 17,975 -201 -1.11 2,445 12.10 0.0117
2018-07-31 2018-06-30 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 18,176 5,331 41.50 2,181 41.17 0.0114
2018-05-14 2018-03-31 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 12,845 -249 -1.90 1,545 -5.33 0.0084
2018-02-12 2017-12-31 13F VANECK VECTORS ETF TR BIOTECH ETF 92189F726 13,094 13,094 1,632 0.0089
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.